Profile data is unavailable for this security.
About the company
Wuhan YZY Biopharma Co Ltd is a China-based company mainly engaged in the discovery, development, and commercialization of new innovative drugs in the field of anti-tumor bispecific antibodies. The Company is committed to developing bispecific antibody (BsAb) based therapies for the treatment of cancer-related complications, cancer, and age-related eye diseases to address the medical needs in oncology and geriatric eye diseases. The Company's core product M701 is a recombinant BsAb that targets human cancer cell surface antigen EpCAM and human T cell surface antigen CD3. The Company's product pipeline also includes Y101D, Y332, Y225, and others.
- Revenue in HKD (TTM)164.23m
- Net income in HKD-88.38m
- Incorporated2010
- Employees106.00
- LocationWuhan YZY Biopharma Co LtdNo. 666 Gaoxin RoadEast Lake High Tech Development ZoneWUHAN 430075ChinaCHN
- Phone+86 2 782668988
- Fax+86 2 768788819
- Websitehttps://www.yzybio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sirnaomics Ltd | 13.90m | -109.55m | 768.78m | 52.00 | -- | -- | -- | 55.32 | -1.33 | -1.33 | 0.161 | -0.3804 | 0.0637 | -- | -- | 201,403.60 | -36.30 | -80.21 | -216.85 | -100.49 | 67.44 | -- | -570.30 | -27,838.86 | -- | -8.20 | -- | -- | -- | -- | 34.70 | -- | -38.10 | -- |
| JW (Cayman) Therapeutics Co Ltd | 201.32m | -699.51m | 941.23m | 292.00 | -- | 0.9141 | -- | 4.68 | -1.69 | -1.69 | 0.4852 | 2.47 | 0.1046 | 1.34 | 9.59 | 716,429.40 | -36.34 | -35.14 | -47.41 | -39.06 | 55.52 | -- | -347.47 | -898.77 | 1.45 | -1,808.42 | 0.2907 | -- | -8.99 | -- | 23.10 | -- | -32.98 | -- |
| Sunho Biologics Inc | 0.00 | -92.97m | 1.00bn | 128.00 | -- | 1.84 | -- | -- | -0.616 | -0.616 | 0.00 | 3.48 | 0.00 | -- | -- | 0.00 | -14.33 | -- | -15.84 | -- | -- | -- | -- | -- | 6.57 | -- | 0.1242 | -- | -- | -- | 39.74 | -- | -- | -- |
| B&K Corp Ltd | 295.61k | -206.83m | 1.09bn | 100.00 | -- | 11.43 | -- | 3,701.60 | -1.76 | -1.76 | 0.0025 | 0.8138 | -- | -- | -- | -- | -- | -- | -- | -- | 92.34 | -- | -69,968.59 | -- | -- | -- | 0.0371 | -- | -44.70 | -- | -101.78 | -- | -- | -- |
| Brii Biosciences Ltd | 0.00 | -425.51m | 1.13bn | 96.00 | -- | 0.3986 | -- | -- | -0.5846 | -0.5846 | 0.00 | 3.91 | 0.00 | -- | -- | 0.00 | -14.05 | -49.92 | -14.09 | -54.57 | -- | -- | -- | -12,750.27 | -- | -- | 0.003 | -- | -100.00 | -- | -190.66 | -- | -33.13 | -- |
| Kintor Pharmaceutical Ltd | 12.44m | -189.22m | 1.39bn | 136.00 | -- | 5.10 | -- | 111.83 | -0.4375 | -0.4375 | 0.0288 | 0.5467 | 0.0194 | 10.66 | 1.06 | 74,049.78 | -29.53 | -47.72 | -44.54 | -55.96 | -55.12 | -36.16 | -1,521.00 | -8,974.73 | 0.4222 | -33.76 | 0.2881 | -- | -- | -- | 85.36 | -- | -53.11 | -- |
| Wuhan YZY Biopharma Co Ltd | 164.23m | -88.38m | 1.40bn | 106.00 | -- | -- | -- | 8.55 | -0.4559 | -0.4559 | 0.8472 | -0.1604 | 0.5805 | 11.54 | 13.96 | 1,453,323.00 | -31.24 | -- | -133.35 | -- | 63.96 | -- | -53.82 | -- | 0.9019 | -24.38 | 1.21 | -- | -- | -- | 49.09 | -- | -- | -- |
| HighTide Therapeutics Inc | 0.00 | -329.76m | 1.49bn | 57.00 | -- | 3.75 | -- | -- | -0.7294 | -0.7294 | 0.00 | 0.6942 | 0.00 | -- | -- | 0.00 | -49.50 | -- | -63.55 | -- | -- | -- | -- | -- | -- | -- | 0.2129 | -- | -- | -- | 59.35 | -- | -- | -- |
| Immunotech Biopharm Ltd | 0.00 | -253.13m | 1.60bn | 173.00 | -- | -- | -- | -- | -0.4523 | -0.4523 | 0.00 | -0.2882 | 0.00 | -- | -- | 0.00 | -37.04 | -36.20 | -186.73 | -45.67 | -- | -- | -- | -- | 0.0712 | -6.63 | 1.48 | -- | -- | -- | 44.18 | -- | 5.95 | -- |
| Cloudbreak Pharma Inc | 78.16m | -326.97m | 1.91bn | 60.00 | -- | -- | -- | 24.47 | -0.3898 | -0.3898 | 0.0932 | -3.08 | -- | -- | -- | 1,532,549.00 | -- | -- | -- | -- | -- | -- | -418.33 | -- | -- | -- | 19.44 | -- | -- | -- | 23.40 | -- | -- | -- |
| ImmuneOnco Biopharmaceuticls Shanghi Inc | 126.96m | -342.81m | 1.98bn | 195.00 | -- | 3.08 | -- | 15.57 | -0.8715 | -0.8715 | 0.3225 | 1.49 | 0.148 | -- | 3,865.48 | 813,859.90 | -40.09 | -- | -51.56 | -- | -- | -- | -270.79 | -- | -- | -- | 0.2236 | -- | 19,109.59 | -- | 16.76 | -- | -- | -- |
| Mabpharm Ltd | 480.14m | -31.12m | 2.10bn | 383.00 | -- | 18.78 | 56.96 | 4.38 | -0.0076 | -0.0076 | 0.1164 | 0.0272 | 0.4209 | 0.4659 | 4.05 | 1,524,243.00 | -2.73 | -19.62 | -4.02 | -25.69 | 86.40 | -- | -6.48 | -211.59 | 0.6906 | -1.58 | 0.7552 | -- | 196.27 | -- | 38.89 | -- | -12.13 | -- |
Data as of Feb 10 2026. Currency figures normalised to Wuhan YZY Biopharma Co Ltd's reporting currency: Hong Kong Dollar HKD
